Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Interest Expenses (2020 - 2025)

Lemaitre Vascular (LMAT) has disclosed Interest Expenses for 7 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 533.17% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 million, a 2428.78% increase, with the full-year FY2025 number at $5.2 million, up 2428.78% from a year prior.
  • Interest Expenses was $1.3 million for Q4 2025 at Lemaitre Vascular, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.3 million in Q2 2025 to a low of $205000.0 in Q4 2024.
  • A 3-year average of $845333.3 and a median of $621000.0 in 2021 define the central range for Interest Expenses.
  • Biggest YoY gain for Interest Expenses was 650.0% in 2021; the steepest drop was 9.0% in 2021.
  • Lemaitre Vascular's Interest Expenses stood at $526000.0 in 2021, then plummeted by 61.03% to $205000.0 in 2024, then soared by 533.17% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Interest Expenses are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025).